Parabilis Medicines, Inc. (PBLS)

40.42 -0.33 (-0.81%) USD  |  NASDAQ  |  Sep 04, 16:00
40.42 0.00 (0.00%) After-Hours: 20:00
More

Parabilis Medicines SG&A Expense (TTM) : 21.36M for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for PBLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2025. Start Trial.
Date Value
June 30, 2026 21.36M
March 31, 2026 9.70M
Date Value
June 30, 2025 0.00
March 31, 2025 0.00

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Moderna, Inc. 965.00M
Kailera Therapeutics, Inc. 34.10M
Arrowhead Pharmaceuticals, Inc. 172.57M
Oncolytics Biotech, Inc. 16.62M
Sangamo Therapeutics, Inc. 31.64M